Diabetic kidney disease reveals an important impairment of adenosine monophosphate- activated protein kinase (AMPK) and sirtuin-1 (SIRT1) signaling, which may contribute to the development and progression of nephropathy. This evidence concerns the gene SIRT1 and diabetic kidney disease.